Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
Status:
Completed
Trial end date:
2007-06-18
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine whether clopidogrel reduces the early failure rate
of native AV fistulae. This study was originally registered as NCT00067119 which included two
protocols, this one and the GRAFT study)
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators:
Baystate Medical Center Boston University CAMC Health System Duke University Emory University Maine Medical Center MaineHealth St. Louis University The Cleveland Clinic Tyler Nephrology Associates University of Alabama at Birmingham University of Iowa University of Texas Southwestern Medical Center Vanderbilt University Vascular Surgery Associates LLC Washington University School of Medicine